Abstract
Patterns of recreational drug use undergo constant change. Health care providers must remain vigilant and informed regarding emerging drugs of abuse to care better for their patients. There is also a role for improved surveillance and characterization of novel drugs. This report reviews the clinical manifestations and toxicity of several new drugs of abuse, including dextromethorphan, hallucinogenic tryptamines (including Foxy Methoxy), hallucinogenic amphetamines (including 2C-B and 2C-T-7), as well as the herbal hallucinogen, Salvia divinorum .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
